Which treatments are currently available for relapsed and refractory myeloma treatment?
Results of the ASPIRE trial for MM: the addition of carfilzomib
Ibrutinib and FCR chemoimmunotherapy: improving complete remission in CLL patients?
When should we start treatment for relapsed multiple myeloma patients?
EBMT 2017: Highlighting the hottest topics in the field of transplantation